ggbet50freespins| Nuocheng Jianhua: Establish a postdoctoral scientific research workstation to accelerate the research and development of innovative drugs

Newsletter summary

Nuocheng Jianhua approved to set up postdoctoral research workstationGgbet50freespinsCEO Cui Jiansong pointed out that the new station will train R & D personnel and promote the development of innovative drugs for the benefit of patients around the world.

Text of news flash

[Nuocheng Jianhua has been approved to set up a postdoctoral research workstation to speed up the creation of new drugs] Nuocheng Jianhua recently announced that the company has been successfully approved to set up a postdoctoral research workstation, which indicates that the company will enter a new stage in the field of new drug research and development. The document of the Office of the National Post-doctoral Management Committee confirmed the matter, and Nuocheng Jianhua will be able to carry out the recruitment and training of postdoctoral students. Cui Jiansong, co-founder, chairman and CEO of the company, said: "Innovation is the life of the biomedical industry, and talent is the core of promoting innovation."Ggbet50freespinsHe stressed that the company has long established an industry-leading new drug creation team to focus on developing innovative first-in-class or best-in-class drugs that address major clinical needs such as malignant tumors and autoimmune diseases. The newly established postdoctoral research station is expected to train more innovative drug research and development personnel, thereby further accelerating the development of new quality productivity and bringing more innovative drugs to patients around the world. This important progress undoubtedly has a high degree of attention for investors in the secondary market. Nuocheng Jianhua's R & D strength and talent strategy in the field of biomedicine will have a positive impact on the company's long-term development and deserve the close attention of market investors.